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ABSTRACT
In this study, we tested whether a standardized epigallocatechin-3-gallate 
(EGCG) rich green tea extract (comprising > 90% EGCG) affects fitness and lifespan 
as well as parameters of glucose metabolism and energy homeostasis in the fruit 
fly, Drosophila melanogaster. Following the application of the green tea extract 
a significant increase in the mean lifespan (+ 3.3 days) and the 50% survival 
(+ 4.3 days) as well as improved fitness was detected. These effects went along 
an increased expression of Spargel, the homolog of mammalian PGC1α, which has 
been reported to affect lifespan in flies. Intriguingly, in flies, treatment with the 
green tea extract decreased glucose concentrations, which were accompanied by an 
inhibition of α-amylase and α-glucosidase activity. Computational docking analysis 
proved the potential of EGCG to dock into the substrate binding pocket of α-amylase 
and to a greater extent into α-glucosidase. Furthermore, we demonstrate that EGCG 
downregulates insulin-like peptide 5 and phosphoenolpyruvate carboxykinase, 
major regulators of glucose metabolism, as well as the Drosophila homolog of leptin, 
unpaired 2. We propose that a decrease in glucose metabolism in connection with an 
upregulated expression of Spargel contribute to the better fitness and the extended 
lifespan in EGCG-treated flies.
INTRODUCTION
The consumption of green tea (Camellia sinensis) 
has been associated with various health benefits [1–4]. 
The leaves of green tea offer a wide spectrum of different 
phytochemicals that may vary according to environmental 
conditions and processing procedures. Approximately 
30% of the green tea dry weight comes from polyphenols 
of which 60–80% are catechins [5]. Catechins and in 
particular epigallocatechin-3-gallate (EGCG), which 
accounts for up to 80% of the catechins, are suggested to 
mediate the health-promoting effects of green tea [6–8].
In fact, studies in various model organisms indicate a 
lifespan extension by green tea and EGCG treatment. This 
has been shown in both invertebrates and in mammalian 
species [9–13]. However, the underlying cellular and 
molecular mechanisms are not clear. Bartholome and 
colleagues observed higher levels of the FoxO ortholog 
DAF-16, which increased the expression of its target gene 
Sod-3, and extended lifespan in Caenorhabditis elegans 
[14]. In Drosophila melanogaster, EGCG extended lifespan 
via an induction of endogenous antioxidant enzymes [12]. 
Additionally, in mice receiving tea polyphenols from the 
13th month of life onward, lifespan was significantly 
longer than in the corresponding control animals [9]. 
Furthermore, rats treated with EGCG also exhibited a 
significantly longer lifespan that was accompanied by a 
decrease in inflammation and oxidative stress as well as an 
increase of FOXO3a and SIRT1, both centrally involved in 
the regulation of longevity [10]. It has been demonstrated 
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that aging is associated with a decrease in mitochondrial 
biogenesis and in consequence with a loss in the expression 
of PPARγ co-activator α (PGC1α), the master switch 
of energy metabolism [15, 16]. Interestingly, green tea 
polyphenols have been shown to induce both PGC1α 
mRNA and protein expression in male Sprague-Dawley 
rats [17].
The aim of the present study was to elucidate the 
underlying mechanisms of the lifespan extending effect 
of a caffeine-free green tea extract containing more than 
90% EGCG in Drosophila melanogaster. We analyzed 
the regulatory effects of EGCG on parameters involved in 
energy homeostasis and glucose metabolism. In addition, 
fitness, as marker for an improved health span, was 
assessed.
RESULTS
EGCG extends lifespan and improves fitness in 
Drosophila melanogaster
The application of 10 mg/ml EGCG increased the 
mean lifespan (+ 3.3 days) and the 50% survival (+ 4.3 
days) compared to control flies (Figure 1a). Flies reared 
on EGCG-supplemented medium for 30 days exhibited a 
significantly higher fitness level in the climbing assay than 
the control flies (Figure 1b).
EGCG inhibits α-amylase and α-glucosidase 
in vitro and in vivo and decreases glucose levels 
in Drosophila melanogaster
EGCG dose-dependently inhibited both α-amylase 
and α-glucosidase in vitro (Figure 2a, 2b). Accordingly, 
flies reared for 10 days on the EGCG-supplemented 
diet showed significantly lower levels of both amylase 
(Figure 2c) and α-glucosidase activity (Figure 2d). As 
shown in Figure 2e, glucose levels were lowered by 25% 
following EGCG-treatment.
Molecular docking of EGCG on human salivary 
α-amylase
In order to gain insight into the putative binding 
mode of EGCG with human salivary α-amylase blind 
docking for EGCG with the crystallographic model of 
apo-amylase was carried out [27]. Figure 3a illustrates a 
predicted binding mode of EGCG snugly fitting into the 
left arm of the polysaccharide-binding cleft of human 
salivary amylase. The binding free energies of a cluster 
of eight binding poses were averaged (−7.29 kcal/mol ± 
SEM = 0.056 kcal/mol) to estimate the affinity from the 
predicted binding intensities of the docking interaction of 
EGCG at the active site of human salivary α-amylase. The 
3D-superposition of the pig amylase:acarbose inhibitor-
complex with the in silico model of human salivary 
α-amylase:EGCG complex produced steric clashes of the 
inhibitor with EGCG in close proximity to the active site.
α-Glucosidase homology model preparation and 
molecular docking of EGCG
Using the web-based SWISS-MODEL service 
dedicated to protein structure homology modeling [29] a 
α-glucosidase homology model was built. Blind docking 
for EGCG with the homology model of α-glucosidase 
was carried out using the web-based SwissDock service 
[27]. Figure 3b illustrates the predicted binding mode of 
EGCG plugging the entry of the substrate-binding cavity 
of the α-glucosidase. The binding free energies of a cluster 
of eight binding poses were averaged (−7.44 kcal/mol ± 
SEM = 0.001 kcal/mol) to estimate the affinity from the 
predicted binding intensities of the docking interaction of 
EGCG at the entry of the binding pocket of α-glucosidase.
EGCG affects the expression of biomarkers 
related to energy homeostasis and energy 
metabolism
Flies treated with EGCG for 10 days exhibited 
higher levels of p-AMPK protein as depicted in Figure 4a. 
Furthermore, flies housed on an EGCG-supplemented 
diet showed significantly higher levels of spargel (srl) 
mRNA expression than the corresponding control flies 
(Figure 4b). Srl is the fly homolog of human PPARγ-
co-activator 1α (PGC1α), the master regulator of energy 
homeostasis. The mRNA expression of unpaired 2 (upd2), 
the homolog of human leptin, was significantly lowered 
in flies that had received EGCG for 10 days compared to 
control animals (Figure 4c). In addition, the key enzyme 
of gluconeogenesis, phosphoenolpyruvate carboxykinase 
(Pepck; Figure 4d), and insulin-like peptide 5 (Ilp5; 
Figure 4e) were significantly downregulated following 
EGCG-treatment for 10 days in comparison to flies 
receiving CM. Furthermore, the expression of Ilp2, 
Ilp3, and Ilp6 as well as the expression of the glucose 
transporters Glut1, Glut3 and Glut4EF was not affected 
by EGCG treatment (data not shown).
DISCUSSION
In the present study we used Drosophila 
melanogaster as a model organism in order to elucidate 
the effect of EGCG on glucose metabolism, fitness 
and lifespan. Drosophila melanogaster offers a wide 
variety of advantages. This includes a short generation 
time, a reasonable number of offspring and a relatively 
short lifespan. Furthermore, it possesses defined organs 
including gut, brain and fat body. Drosophila melanogaster 
holds a complex and dynamic gut exhibiting a similar 
structure and organization like the mammalian gut 
predestining it as a feasible model organism in nutrition 
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research [32–35]. The application of the EGCG-rich 
green tea extract significantly extended lifespan in male 
flies. Similarly to our results indicating that EGCG only 
extended the lifespan in male but not in female flies (data 
not shown), Lopez and co-workers found that lifespan 
is only extended in male but not in female Drosophila 
melanogaster following EGCG application [13]. It has 
also been shown that in male flies a lifelong intake of 
10 mg/ml green tea catechin extract extended the mean 
lifespan (59 ± 2.8 days) compared to the corresponding 
control flies (51 ± 2.0 days) [12].
We identified EGCG as an inhibitor of α-amylase 
and α-glucosidase, which may cause the attenuated 
glucose levels in our flies as the expression levels of the 
glucose transporters were not affected. We could also 
show via computational docking studies that EGCG fits 
into binding boxes of both α-amylase and α-glucosidase. 
In the case of α-amylase the docking results indicate 
competitive inhibition by EGCG through a single high-
affinity binding site located close to the active center. 
In contrary docking with α-glucosidase rather suggests 
a noncompetitive inhibition mode with EGCG blocking 
the entry of the deeply buried substrate-binding site. Our 
results also demonstrate that the blocking effect of EGCG 
is stronger with regard to α-glucosidase than α-amylase. 
Interestingly, a recent study conducted by Harrison and 
co-workers identified the α-amylase inhibitor acarbose as 
a compound that extends lifespan in mice [36].
Tinkerhess and colleagues showed that, as in 
mammals, endurance exercise caused an upregulation 
of the PGC1α homolog srl in Drosophila melanogaster. 
Interestingly, in mutant srl flies, the positive effect of 
exercise is abolished whereas an overexpression of srl 
in the muscle and the heart of the mutant flies improved 
some exercise-related physiological parameters [37]. 
A 30 day application of the EGCG-rich tea extract to our 
flies resulted in improved climbing activity that may be 
related to the significant increase of the srl expression 
and consequently to a potential increase in mitochondrial 
biogenesis. These characteristics may also contribute to 
the extension in lifespan. The weakness of the current 
study is a missing experiment with srl mutant flies. Further 
studies are needed to investigate the effects of EGCG on 
srl mutants.
We were able to detect changes in the expression of 
parameters involved in energy metabolism. With regard 
to the insulin-like peptides (Ilps), Ilp5 was found to be 
significantly downregulated by EGCG in our Drosophila 
melanogaster. Min and co-workers also observed a 
downregulation of Ilp5 mRNA levels following dietary 
restriction [38, 39], and another group demonstrated 
that yeast dietary restriction (DR) (in the fly medium 
the percentage of yeast was decreased although the 
percentage of carbohydrate remained constant) caused 
a downregulation of both Ilp5 mRNA and protein levels 
[38, 40]. At the same time, the glucose levels in our 
EGCG-treated flies were significantly lower than in the 
corresponding control flies, which may explain the extension 
in lifespan by EGCG. Glucose has been described as a pro-
aging factor that interferes with all relevant regulators of 
the aging process [41, 42]. This has also been reported by 
Schulz and co-workers who observed a decrease in lifespan 
of Caenorhabditis elegans due to high glucose availability 
while glucose restriction resulted in an extended lifespan 
through an induction of the mitochondrial respiration 
[43]. The downregulation of the rate-controlling enzyme 
in gluconeogenesis, Pepck, may have also contributed to 
the lower glucose levels in our EGCG-treated flies. This 
Figure 1: Effect of EGCG (10 mg/ml) supplementation on lifespan in male W1118 Drosophila melanogaster. a. One 
representative experiment out of two is shown. n = 120 flies per group, p < 0.05 log-rank test. b. Relative fitness levels of male W1118 
Drosophila melanogaster reared on an EGCG (10 mg/ml)-supplemented diet for 30 days. The data are expressed as the mean + SEM 
(n = 100). * indicates significant differences compared to the control group (p < 0.05, Student’s t-test).
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result is in contrast to the fact that an increase in PGC1α is 
related to an upregulation of gluconeogenesis including an 
induction of Pepck [44]. Indeed, our results are supported 
by two recent studies. Aatsinki and co-workers [45] showed 
an upregulation of hepatic PGC1α and a simultaneous 
impairment of hepatic Pepck by metformin treatment in 
both human primary hepatocytes and mice. Metformin is 
an anti-diabetic drug used clinically for decades and known 
for its AMPK-inducing and lifespan extending effects 
[46–49]. Doan et al. [50] treated mice with gallic acid (GA), 
a natural polyphenol, and observed a significant induction 
of AMPK activation accompanied by an increase in PGC1α 
and a decrease in Pepck expression. In Caenorhabditis 
elegans it has been shown that aak-2, a homolog of the 
mammalian AMPK, is essentially required to extend 
lifespan due to glucose restriction. Schulz and colleagues 
suggest that the glucose restriction increases the levels of 
reactive oxygen species resulting in an induction of the 
endogenous antioxidant machinery consequently leading to 
an improved stress resistance which the authors refer to as 
“mitohormesis” [43]. The inhibition of gluconeogenesis in 
the present study may be at least partly mediated through 
an induction of AMPK by EGCG [51]. These results may 
imply that an EGCG treatment mimics the effects of caloric 
restriction (CR). To date, CR is the only established method 
to extend health and lifespan in primates [52–54].
Our results indicate that EGCG significantly extended 
lifespan in male flies, which was accompanied by improved 
fitness. For the first time, we confirmed the inhibitory effect 
of EGCG on α-amylase and α-glucosidase activity in vitro 
and in vivo in Drosophila melanogaster. Computational 
docking analysis proved the potential of EGCG to dock into 
the substrate binding pocket of α-amylase and to a greater 
extent into α-glucosidase. By lowering the activity of 
these enzymes, EGCG causes a decrease in calorie uptake 
resulting in lower levels of glucose and Ilp5. The lowered 
energy intake also causes a significant downregulation of 
the leptin homolog upd2. The inhibition of the rate-limiting 
enzyme of gluconeogenesis, Pepck, is potentially mediated 
through an activation of AMPK by EGCG, which also 
Figure 2: EGCG-dependent inhibition of α-amylase and α-glucosidase activity in vitro (a, b) and in vivo (c, d) and 
decrease of glucose levels in vivo (e). Dose-dependent inhibition of a. α-amylase and b. α-glucosidase by EGCG in vitro. The data 
are expressed as the mean + SEM (n = 3). c. α-amylase activity, d. α-glucosidase activity, and e. glucose levels of male W1118 Drosophila 
melanogaster relative to fly weights. Flies were reared on an EGCG (10 mg/ml)-supplemented or control diet for 10 days. The data are 
expressed as the mean + SEM (n = 5–6, indicating extraction from 5–6 × 5 flies). * indicates significant differences in EGCG-treated flies 
compared to flies fed control medium for 10 days (p < 0.05, Student’s t-test).
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causes the significant upregulation of srl, the master switch 
of mitochondrial biogenesis. The postulated mechanism is 
summarized in Figure 5.
Energy excess is the main cause of accelerated 
aging [55]. Limiting calorie intake may counteract the 
deleterious effects of aging [56]. We propose that EGCG 
may function as a potential caloric restriction mimetic, 
thereby affecting health and lifespan, which needs to be 
confirmed in future in vivo studies in mammalian species.
MATERIALS AND METHODS
Drosophila melanogaster stocks
In the present study W1118 wild-type Drosophila 
melanogaster were used for all experiments. Flies were 
maintained under conventional conditions on 10% 
Caltech (CT) medium (5.5% dextrose, 3.0% sucrose [both 
Carl Roth, Karlsruhe, Germany], 6.0% corn meal, 2.5% 
inactive dry yeast, 1.0% agar, 0.3% nipagin [all Dominique 
Dutscher SAS, Brumath, France] and 0.3% propionic acid 
[Carl Roth, Karlsruhe, Germany]) in a constant climate 
chamber (HPP 1018, Memmert, Schwabach, Germany) 
with a temperature of 25°C, 60% relative humidity and 
a 12-h day/night cycle. For all experiments, age-matched 
flies from synchronized eggs were used.
Gustatory assay
In order to exclude differences in food intake as 
reason for differing results between control flies and 
tea polyphenol treated flies, the gustatory assay was 
performed using the method of Bahadorani et al. [18]. 
Fifteen flies were either kept on control medium (CM; 
5% sucrose, 8.6% corn meal, 5% inactive dry yeast, 0.5% 
agar) or isocaloric CM supplemented with 10 mg/ml tea 
polyphenols (EGCG; Teavigo, DSM, Basel, Switzerland). 
They were reared under standard conditions (25°C, 60% 
relative humidity, 12-h day/night cycle), and the medium 
was changed at least 2 times during this period. After 5 
days, flies were transferred onto CM or EGCG stained 
with 0.2% sulforhodamine B sodium salt (Sigma-Aldrich, 
Steinheim, Germany) and kept under standard conditions 
for 15 h. Flies were anesthetized and sorted to an arbitrary 
redness index of their abdomens (colorless = 0, partly 
colored = 0.5, fully red colored = 1.0). The food intake did 
not differ between control flies and EGCG-treated flies.
Lifespan experiments
Twelve vials containing 20 male flies each were 
divided into two groups. One group (n = 120) received 
CM; the other group (n = 120) received the EGCG-
supplemented diet. Flies were reared under standard 
Figure 3: Predicted binding modes of EGCG docked with the X-ray structure of human salivary α-amylase and with the 
homology model of α-glucosidase from baker’s yeast. a. The interaction between EGCG and human salivary α-amylase. Illustration 
of the surface of the substrate binding cleft with bound EGCG (green sticks) and the 3D-superposed acarbose (yellow sticks) from pancreatic 
α-amylase to visualize pseudo-substrate position (yellow) within the ligand binding cleft relative to docked EGCG inhibitor (green). b. The 
interaction between EGCG and α-glucosidase from baker’s yeast. Illustration of the surface of the substrate binding cavity bound to its 
competitive inhibitor maltose (grey sticks) relative to docked EGCG (green sticks). Images were depicted using the Pymol software.
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conditions (25°C, 60% relative humidity, 12-h day/night 
cycle), and the medium was changed every 2–3 days. This 
procedure was adopted for all experiments of the study if 
not otherwise noted. Dead flies were counted every 2–3 
days and analyzed for survivorship using dLife [19].
Climbing assay
Climbing ability was assayed as an indicator of 
overall fitness of the flies. Flies were maintained under 
standard conditions and received either CM (n = 100) or 
EGCG (n = 100) for 30 days. On day 30, the flies were 
transferred into empty vials and the RING-assay described 
by Gargano et al. [20] was performed. In brief, vials with 10 
flies each were placed in a box containing a metering rule. 
The vial-containing box was rapidly tapped three times on 
the table, and a photo was taken after 4 s of climbing time. 
This procedure was repeated ten times with a 30 second 
break between trials. Data analysis was performed using the 
method of Bazzell et al. [21] with modifications.
Figure 4: Protein (a) and mRNA (b-e) levels of genes involved in energy homeostasis in Drosophila melanogaster.  
a. p-AMPK protein levels analyzed in whole fly homogenates following a 10 day treatment of male W1118 Drosophila melanogaster with 
10 mg/ml EGCG. b. spargel (srl), c. unpaired 2 (upd2), d. phosphoenolpyruvate carboxykinase (Pepck), and e. insulin-like peptide 5 (Ilp5) 
mRNA levels of genes involved in energy homeostasis measured in whole fly homogenates after a 10 day supplementation period of male 
W1118 Drosophila melanogaster with 10 mg/ml EGCG. The data are expressed as the mean + SEM (n = 3, indicating extraction from 3 × 5 
flies). * indicates significant differences in EGCG-treated flies compared to flies fed control medium for 10 days (p < 0.05, Student’s t-test).
Oncotarget30574www.impactjournals.com/oncotarget
Glucose analysis
Flies were maintained either on CM (n = 15) or 
EGCG (n = 15) under standard conditions for 10 days. Five 
flies were homogenized in 250 μl PBS plus 0.01% Triton™ 
X-100 (Sigma-Aldrich, Steinheim, Germany) using a 
Qiagen TissueLyser II (Hilden, Germany) at 4°C and 5000 
× g for 10 min. Fly lysates were centrifuged at 5000 × 
g at 4°C for 10 min. The supernatant was removed and 
stored at −80°C until use. Glucose levels were detected by 
Fluitest®GLU (Analyticon Biotechnologies, Lichtenfels, 
Germany) according to the manufacturer’s instructions. 
Sample concentrations were calculated via the standard 
curve and related to the corresponding fly weights per fly.
In vitro α-amylase and α-glucosidase assay
The α-glucosidase and α-amylase inhibition assay 
was performed using the method of Phan et al. [22] with 
modifications. To test α-glucosidase inhibition, 50 μl of 
test sample/H
2
O were mixed with 100 mmol/l KH
2
PO
4
 
(pH = 6.8) and 50 μl α-glucosidase (0.5 U/ml, Sigma-
Aldrich, Steinheim, Germany) and incubated at 37°C for 5 
min. One unit of enzyme activity is defined as the amount 
of enzyme that is needed for the liberation of 1 μmol of 
p-nitrophenol from p-nitrophenyl-α-D-glucopyranoside 
(pNPG). Subsequently, 50 μl of 10 mmol/l pNPG was 
added, mixed and incubated at 37°C for 20 min. The reaction 
was stopped by adding 2 mol/l Na
2
CO3. The absorbance 
of the liberated p-nitrophenol was measured at 405 nm in 
a plate reader (Tecan, Crailsheim, Germany). To test for 
α-amylase inhibition, 50 μl of test sample/H
2
O were mixed 
with 50 μl 1% starch solution and 50 μl α-amylase (10 U/ml, 
Sigma-Aldrich, Steinheim, Germany) and incubated at 
20°C for 3 min. Subsequently, 50 μl of color reagent 
(44 mM 3,5-Dinitrosalicylic Acid Solution (DNS) with 1.1 M 
Sodium Potassium Tartrate Solution) and 50 μl α-amylase 
(as a control) were added, mixed, spun down and incubated 
Figure 5: Schematic summary of the postulated mechanism how EGCG mediates lifespan extension and improved 
fitness in Drosophila melanogaster (for detailed description see text).
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at 99°C for 15 min. After cooling, 450 μl H
2
O was added, 
and the absorbance was measured at 540 nm in a plate reader 
(Tecan, Crailsheim, Germany). The % inhibition of enzyme 
activity was calculated by the following formula ((Δ H
2
O - Δ 
sample)/Δ H
2
O)*100; Δ = absorbance test group (including 
enzyme) - absorbance control group (without enzyme). 
Acarbose was used as positive control. Acarbose and EGCG 
were dissolved in H
2
O.
In vivo α-glucosidase and amylase activity assay
Flies were maintained either on CM (n = 39) or 
EGCG (n = 39) under standard conditions for 10 days. Per 
group, 13 male flies were homogenized in 250 μl Ca2+/
Mg2+-free PBS (Gibco, Darmstadt, Germany) using a 
Qiagen TissueLyser II (Hilden, Germany). Homogenates 
were centrifuged at 13,000 × g at 4°C for 10 min. 
Supernatants were removed and used for enzyme activity 
measurements.
The α-glucosidase activity assay (MAK123, Sigma-
Aldrich, Steinheim, Germany) was performed according 
to the manufacturer’s instructions.
The amylase activity assay (MAK009, Sigma-
Aldrich, Steinheim, Germany) was conducted according 
to the manufacturer’s instructions. Enzyme activities were 
related to the corresponding fly weights per fly.
Docking analysis
X-ray structural models of human salivary 
α-amylase (PDB ID: 1SMD [23]), isomaltase from 
Saccharomyces cerevisiae (PDB ID: 3A4A [24]) and pig 
pancreatic α-amylase (PDB ID: 1PPI [25]) were obtained 
from the Protein Data Bank at Brookhaven. The EGCG 
3D-structure was obtained from the Zinc database (EGCG: 
Zinc ID 3870412) [26]. The human salivary α-amylase 
structure was prepared for docking by removing from the 
crystallographic structure ions and water molecules. Since 
the salivary R-amylase X-ray structure does not contain 
hydrogen atoms, H-atoms were added to the enzyme prior 
to docking by the SwissDock web-service [27]. (The web 
service SwissDock is based on fast docking using the 
CHARMM force field with the docking software EADock 
DSS [28]). For structure homology modeling the sequence 
of α-glucosidase (gi|411229) from baker’s yeast and the 
high resolution X-ray structure of isomaltase (PDB ID: 
3A4A [24]) were submitted to the web-based service of 
SwissModel [29] along previously reported methods [30]. 
The obtained target-template sequence similarity (SID = 
72.3) and the global model quality estimation (GMQE = 
0.92) were judged to be suitable for docking experiments. 
Molecular analyses were performed with the UCSF 
Chimera package. Chimera is developed by the Resource 
for Biocomputing, Visualization, and Informatics at the 
University of California, San Francisco (supported by 
NIGMS P41-GM103311) [31].
RNA isolation and real time PCR
Total RNA was isolated from 5 flies per 
sample using peqGOLD TriFast™ (Peqlab, Erlangen, 
Germany) according to the manufacturer’s protocol. 
RNA concentration was determined by measuring 
the absorbance with a NanoDrop® spectrophotometer 
(Thermo Scientific, Langenselbold, Germany), and the 
RNA purity was assessed by calculating the 260/280-
nm and 260/230-nm ratios. RNA aliquots were stored 
at −80°C until the PCR was performed. The primers for 
Drosophila melanogaster genes were designed using 
Primer3 software and were synthesized and purchased 
from MWG Biotech, Ebersberg, Germany (see Table 1). 
The real time PCR was performed using the SensiFast™ 
SYBR® No-ROX One-Step kit (Quantace, Berlin, 
Germany) on a Rotor-Gene 6000 cycler (Corbett Life 
Science, Sydney, Australia). The relative mRNA levels 
of the target genes were calculated relative to the 
expression of the housekeeping gene ribosomal protein 
l32 (rpl32).
Western blotting
Per group, 5 flies were homogenized in RIPA 
buffer (50 mmol/l Tris, 150 mmol/l NaCl, 0.5% sodium 
deoxycholate (v/v), 0.1% SDS (w/v) and 1% NP-40 (v/v), 
at pH 7.4) supplemented with phosphatase and proteinase 
inhibitors in a Qiagen TissueLyser II (Hilden, Germany). 
Table 1: Primer sequences (Drosophila melanogaster) used for real time PCR
gene forward primer (5′ → ‘3) reverse primer (3′ → ‘5) PCRproduct (bp) annealing temperature (°C)
Ilp5 tgatggacatgctgagggtt catgtggtgagattcggagc 128 57
Pepck ccgccgagaaccttattgtg agaatcaacatgtgctcggc 136 57
rpl32 ggcaagcttcaagatgacca gttcgatcctaaccgatgt 198 58
spargel ctcttggagtccgagatccgcaa gggaccgcgagctgatggtt 90 64
upd2 atgatcctgagcgtcgtgat cccgatgatgaggatgacga 131 59
Abbreviations: Ilp5 = insulin-like peptide 5; Pepck = phosphoenolpyruvate carboxykinase; rpl32 = ribosomal protein l32; 
upd2 = unpaired 2; bp = base pairs
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Samples were incubated on ice for 30 min and centrifuged at 
13,000 × g at 4°C for 20 min. The supernatant was aliquoted 
and stored at −80°C until analysis. Protein concentrations 
were detected using the Pierce™ BCA protein assay kit 
(Darmstadt, Germany) according to the manufacturer’s 
instructions. A quantity of 50 μg of each sample was heated 
with loading buffer and separated on a 4–20% ready-to-
use gel (Bio-Rad, Munich, Germany). Then, samples were 
transferred onto a polyvinylidenedifluoride membrane 
(Bio-Rad, Munich, Germany) and blocked with 5% (w/v) 
skim milk dissolved in Tris-buffered saline + 0.05% (v/v) 
Tween 20 for 2 h. Membranes were probed overnight 
with p-AMPK (#2535, 1:1000, Cell Signaling, Frankfurt, 
Germany), AMPK (#ab80039, 1:1000, Abcam, Cambridge, 
UK) and α-tubulin (#2125, 1:1000 Cell Signaling, Frankfurt, 
Germany) primary antibodies followed by incubation with 
the corresponding secondary antibodies, anti-rabbit (1:4000, 
Bio-Rad, Munich, Germany) for p-AMPK and α-tubulin 
and anti-mouse (1:4000, Bio-Rad, Munich, Germany) for 
AMPK, at room temperature for 1 h. Bands were visualized 
with ECL substrate (Thermo Fisher Scientific, Schwerte, 
Germany) in a ChemiDoc XRS System (Bio-Rad, Munich, 
Germany) using Quantity One Software (version 4.6.3; Bio-
Rad, Munich, Germany).
Statistics
Analysis of lifespan and stress test experiments was 
performed with dLife (freeware, available from the laboratory 
of Scott Pletcher, University of Michigan, Ann Arbor, 
MI, USA). Survival was calculated using a Kaplan-Meier 
approach, and significant differences were calculated applying 
the log-rank test with the dLife program based on R. Mean and 
median survival times were calculated with SPSS (Statistical 
Package for the Social Sciences, IBM, Armonk, NY, USA). 
All other data were analyzed for significant differences using a 
one-way ANOVA followed by a Student’s t-test. All data were 
tested for normality of distribution (Kolmogorov-Smirnov and 
Shapiro-Wilk) and homogeneity of variances (Levene’s test). 
P < 0.05 was considered significant. The data are expressed 
as the mean ± SEM.
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